GOLD classification of COPD: discordance in criteria for symptoms and exacerbation risk assessment. COPD. 2017; 14(1):1-6.GOLD Classification of COPD:Discordance in Criteria for Symptoms and Exacerbation Risk Assessment. Mittal R,Chhabra SK. COPD Journal of Chronic Obstructive Pulmonary Disease . ...
"GOLD criteria for COPD" is a mobile app designed to help health practitioner or medical doctor to assess different stages of chronic obstructive pulmonary disease (COPD). GOLD stands for Global Initiative for Obstructive Lung Disease. There are several features of "GOLD criteria for COPD", namely...
Criteria for GOLD Stage 0 was fulfilled by 5.8% of the total adult population and 7.2% of smokers. After 5 and 15 years, 13.2 and 20.5%, respectively, of smokers with GOLD Stage 0 had developed COPD fulfilling criteria for GOLD Stage 1 or worse. This was the case for 11.6 and 18.5%...
According to the Global initiative for chronic Obstructive Lung Disease (GOLD) criteria, COPD patients are classified into GOLD stage I (Mild), Stage II (Moderate), Stage III (Severe) and Stage IV (Very severe) based on the severity of airflow limitation19. In this study, we have employed...
OBJECTIVE: To determine whether in a high-risk group of middle-aged male current smokers, patient characteristics are useful to recognize mild COPD (GOLD stage I). DESIGN: In a cross-sectional study spirometry was performed according to the American Thoracic Society criteria. COPD was defined acco...
Background: Tobacco smoking is more prevalent among the elderly than among the young, and the elderly also have the most frequent contact with the health care system. The aim of this study was to evaluate the effectiveness of the Gold Standard Program, w
Through the development of evidence-based strategy documents for management of both COPD, and events such as the annual World COPD Day and the yearly GOLD International COPD Conference, GOLD is working to improve the lives of people with COPD in every corner of the globe. GOLD REPORT The GOLD...
Methods DYNAGITO was a 52-week, double-blind trial in which patients with COPD were randomized (1:1) to receive T/O 5/5g or Tio 5g once daily, delivered via Respimat (NCT02296138). Patients continued to take inhaled corticosteroids (ICS) if receiving them at baseline. Inclusion criteria ...
Impact of diagnostic criteria on the prevalence of COPD Clin. Respir. J., 7 (3) (2013), pp. 297-303 CrossrefView in ScopusGoogle Scholar [38] A. Pottegard, R. Christensen, A. Houji, C.B. Christiansen, M.S. Paulsen, J.L. Thomsen, et al. Primary non-adherence in general practic...
Mention removal, hashtag removal and URL removal are all textual characteristics of the user that are removed during the preprocessing stage. Aside from that, retweets with no new content were also removed. Then each tweet vector was fed into the trained model separately to get a prediction, ...